The detection of ABETA42 in plasma and CSF is shown to be an accurate marker for differentiating AD from other forms of dementia [25], and detection of high levels of Aβ42 and hyperphosphorylated tau protein in CSF is associated with increased load of AD histopathological hallmarks in the brain [26]. The gene discussed is MAPT; the disease is Alzheimer disease.